#USA #Cambrex #East Rutherford #Snapdragon Chemistry #Song Lin

Cornell University Professor Wins Prestigious Snapdragon Prize

EAST RUTHERFORD, New Jersey – Cambrex, a leading global contract development and manufacturing organization (CDMO), proudly announces that Dr. Song Lin, a professor of chemistry and chemical biology at Cornell University's College of Arts and Sciences, has been awarded the 2025 Snapdragon Prize for Innovation in Chemistry Technology. This award includes an unrestricted fund of $50,000 designated for the Lin Lab.

Dr. Lin is recognized for his groundbreaking research in electrosynthetic chemistry, which aims to expand the use of electrochemistry in developing and manufacturing pharmaceuticals. His laboratory focuses on advancing organic chemistry, electrosynthesis, catalysis, and technological development. Recent advancements made by Dr. Lin in sustainable electrochemical techniques for synthesizing complex organic molecules, including chiral compounds crucial for pharmaceutical innovations, have set new benchmarks for efficiency and environmental responsibility within the field.

"Cambrex is committed to pushing the boundaries of pharmaceutical science through innovation and partnerships," said Matthew Bio, Chief Scientific Officer at Cambrex. "Dr. Lin's pioneering work in electrosynthetic chemistry exemplifies the spirit of the Snapdragon Prize and our commitment to supporting transformative research that will shape the future of drug discovery and manufacturing."

Dr. Lin's numerous accolades include being a finalist for the 2025 Blavatnik National Award, winning the Arthur C. Cope Scholar Award in 2023, being among the most cited researchers by Clarivate in 2025, and receiving the Green Chemistry Challenge Award in 2022. These honors reflect his leadership and lasting impact on the scientific community.

Established in 2024 by Snapdragon Chemistry, the Snapdragon Prize is awarded annually to a leading academic researcher in synthetic chemistry or engineering whose work has the potential to make a significant impact on the discovery and manufacturing of pharmaceutical products. Previous recipients include Professor Todd Hyster from Princeton University and the Hyster Lab. This prestigious award underscores Cambrex’s dedication to scientific excellence and innovation in the development of complex small molecules, supporting the next generation of breakthroughs in pharmaceutical science.

About Cambrex

Cambrex is a prominent global CDMO that provides drug substance development and manufacturing services throughout the product lifecycle, along with comprehensive analytical services and support for new drug research. With over 45 years of experience and a team of 2,000 experts serving international clients in North America and Europe, Cambrex offers a wide range of specialized technologies and capabilities in drug substances, including continuous flow, controlled substances, peptide synthesis, solid-state science, material characterization, and highly potent active pharmaceutical ingredients.